Maze Therapeutics, Inc. (MAZE) stock
MAZENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$31.20−1.67 (-5.08%)
Close on Nov 18, 2026Market cap $1.73BP/E –Yield –
Maze Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Maze Therapeutics's profit margin for the twelve months ending Dec 31, 2024 was 31.2%. For fiscal 2024 it was 31.2%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 31.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -121.0% | – |
| Q3 FY2024 | Sep 30, 2024 | -990.1% | – |
| Q2 FY2024 | Jun 30, 2024 | 84.3% | – |
See a number that looks wrong?